Home > Insider Trading > Filing (0000899243-21-014861)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1088856	Corcept Therapeutics Inc	CORT	Pharmaceutical Preparations (2834)	770487658

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1817838	Douglas Joseph Lyon	C/O Corcept Therapeutics Incorporated 149 Commonwealth Drive Menlo Park CA 94025	Chief Accounting Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-04-01	25,000	$11.35	25,000	No	4	M	Direct
Common Stock	Disposition	2021-04-01	25,000	$23.88	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2021-04-01	25,000	$0.00	25,000	$11.35

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
75,000		2029-02-08	No	4	M	Direct

Footnotes

These transactions were made pursuant to the terms of a 10b5-1 plan in effect at the time of sale of the shares.
Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $23.79 to $24.13 per share. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.
Shares subject to this stock option vest and become exercisable at the rate of 1/48th of the total number of shares on each monthly anniversary of February 8, 2019, so that the total number of shares subject to this option becomes fully vested and exercisable on February 8, 2023.